GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Ending Cash Position

MediPharm Labs (STU:MLZ) Ending Cash Position : €11.50 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs Ending Cash Position?

MediPharm Labs's Ending Cash Position for the quarter that ended in Mar. 2024 was €11.50 Mil.

MediPharm Labs's quarterly Ending Cash Position increased from Sep. 2023 (€8.97 Mil) to Dec. 2023 (€12.29 Mil) but then declined from Dec. 2023 (€12.29 Mil) to Mar. 2024 (€11.50 Mil).

MediPharm Labs's annual Ending Cash Position declined from Dec. 2021 (€23.58 Mil) to Dec. 2022 (€16.78 Mil) and declined from Dec. 2022 (€16.78 Mil) to Dec. 2023 (€12.29 Mil).


MediPharm Labs Ending Cash Position Historical Data

The historical data trend for MediPharm Labs's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Ending Cash Position Chart

MediPharm Labs Annual Data
Trend Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 26.40 12.78 23.58 16.78 12.29

MediPharm Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.75 10.24 8.97 12.29 11.50

MediPharm Labs Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MediPharm Labs's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.504+-4.214
=12.29

MediPharm Labs's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=12.221+-0.717
=11.50


MediPharm Labs Ending Cash Position Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


MediPharm Labs (STU:MLZ) Business Description

Traded in Other Exchanges
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines